In-vivo effects of nociceptin and its structural analogue [Orn9] nociceptin on the antioxidant status of rat blood and liver after carrageenan-induced paw inflammation
Author:
Petrov Lubomir1, Tzvetanova Elina1, Pavlova Almira1, Alexandrova Albena1, Zamfirova Rositsa1, Kirkova Margarita1, Todorov Simeon1
Affiliation:
1. 1Institute of Neurobiology, Bulgarian Academy of Sciences, 23 Acad. G.Bonchev St., 1113, Sofia, Bulgaria
Abstract
AbstractThe production of reactive oxygen species (ROS) in cells is well balanced with their elimination by the antioxidant defence system. This balance is essential for maintenance of physiological conditions, and its disturbance (oxidative stress) has been suggested as a potential pathogenic mechanism in a variety of diseases, accompanied by inflammation. In this study, the in-vivo effects of nociceptin (N/OFQ(1–13)NH2) and its structure analogue [Orn9]N/OFQ(1–13)NH2 were studied on markers of oxidative stress in erythrocytes and liver of rats 4 hours after subplantar administration of carrageenan (CG) (1%, 100 µl) in the right hind paw. A considerable inflammatory oedema of the paw was observed. CG did not change blood haemoglobin content, hematocrit value, glutathione level and antioxidant enzyme activities in the erythrocytes, but there was an increase in lipid peroxidation. In liver, CG-induced imbalance was manifested by an increase in lipid peroxidation and a decrease in glutathione level. Both peptides (20 µg, i.p.), when administered alone, had no effect on all parameters tested. When either [Orn9]N/OFQ(1–13)NH2 or N/OFQ(1–13)NH2 was injected simultaneously with CG or 15 minutes before it, they did not affect the CG-induced changes in the antioxidant status of the erythrocytes and liver. Our results suggest that the peptides tested did not play a role in the free radical processes that accompany CG-induced paw inflammation.
Publisher
Walter de Gruyter GmbH
Reference59 articles.
1. Calo G., Guerrini R., Rizzi A., Salvadori S., Regoli D., Pharmacology of nociceptin and its receptor: a novel therapeutic target (review), Brain J. Pharmacol., 2000, 129, 1261–1283 2. Chiou L.C., Liao Y.Y., Fan P.C., Kuo P.H., Wang C.H., Riemer C., Prinssen E.P., Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications, Curr. Drug Targets, 2007, 8(1), 117–135 3. Wei Y., Ouyang D., Liu Y., Chang Z., Tang J., Ding J., Peripheral tissue distribution of orphanin FQ precusor mRNA in stroke-prone spontaneously hypertensive rats, Clin. Med. Sci. J., 1999, 14(2), 67–70 4. Boom A., Mollereau C., Meunier J.C., Vassart G., Parmentier M., Vanderhaeghen J.J., Schiffmann S.N., Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system, Neuroscience, 1999, 91(3), 991–1007 5. Doggrell S.A., Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target? Curr. Opin. Investig. Drugs, 2007, 8(9), 742–749
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|